Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140009/S139

Infinity DBS IPG

ABBOTT MEDICAL · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONP140009/S139

What did the FDA approve?

The FDA's decision record for P140009/S139, dated 2026-09-23, shows approval of a real-time process supplement classified under a change in design, components, specifications or materials. The stated scope is a material change to the encapsulant used in the printed circuit board assembly during manufacture. The affected devices named in the statement are the Proclaim Spinal Cord Stimulator, Proclaim Dorsal Root Ganglion stimulator and Infinity Deep Brain Stimulator implantable pulse generator.

S139 is a supplement to PMA P140009, which the identifier ties to the original approval; it covers a manufacturing material substitution, not a fresh approval of an entire device system. The listing carries product code MHY, the neurology category Stimulator, electrical, implanted, for parkinsonian tremor, and Abbott Medical as applicant. The record does not state encapsulant identity, concentration, process validation results, or separate safety or clinical effectiveness evidence; approval reflects the agency's action on the change.

FDA approval order statement

approval for a material change to the encapsulant used in the printed circuit board assembly (PCBA) during the manufacture of the Proclaim Spinal Cord Stimulator (SCS), Proclaim Dorsal Root Ganglion (DRG) stimulator and Infinity Deep Brain Stimulator (DBS) Implantable Pulse Generator (IPG) devices.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Neurology
Decision date
Sep 23, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140009/S139
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
APPR
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140009 · Original PMA

    BRIO NEUROSTIMULATION SYSTEM

  2. P140009/S139 received

    Application receipt date recorded by FDA.

  3. P140009/S140 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  4. P140009/S139 · FDA decision

    Real-Time Process

  5. P140009/S143 · Related supplement

    Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator

  6. P140009/S141 · Related supplement

    Deep Brain Stimulation (DBS) EPG

  7. P140009/S142 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  8. P140009/S144 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140009

Explore the linked device profile

Other records with product code MHY

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Prestion Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records